Biomedical Research and Development Price Index (BRDPI) Survey

Forms and Documents

Document Name	Status
Form Biomedical Researc Biomedical Research and Development Price Index (BRDPI) Survey Form and Instruction	Modified
Cover Letter 2020.docx Supplementary Document	2020-09-01
2020 BRDPI Supporting Statement Part A.docx Supporting Statement A	2020-08-28
2020 BRDPI Supporting Statement Part B.docx Supporting Statement B	2020-08-28

IC Document Collections

IC ID	Document Title	Status
3740	Biomedical Research and Development Price Index (BRDPI) Survey Form and Instruction	Modified

ICR Details

OMB Control No: 0608-0069	ICR Reference No: 202004-0608-013
Status: Active	Previous ICR Reference No: 201708-0608-001
Agency/Subagency: DOC/EASA	Agency Tracking No: 2020 BRDPI Renewal
Title: Biomedical Research and Development Price Index (BRDPI) Survey
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 09/02/2020
	Date Received in OIRA: 07/13/2020
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2023	36 Months From Approved	10/31/2020
Responses	150	0	120
Time Burden (Hours)	2,400	0	1,920
Cost Burden (Dollars)	0	0	0

---

Abstract: The survey is used to obtain fiscal year data on expenditures relating to biomedical research and development awards and to update and re-base the BRDPI. Data are obtained from organizations which are recipients of biomedical research and development awards from the National Institutes of Health.

---

Authorizing Statute(s): US Code: 45 USC Subpart C, Section 75 Name of Law: null
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 21824	04/20/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 41948	07/13/2020
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Biomedical Research and Development Price Index (BRDPI) Survey	Biomedical Research & Development Price Index	Biomedical Research & Development Price Index (BRDPI)

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	150	120	0	30	0	0
Annual Time Burden (Hours)	2,400	1,920	0	480	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: No change to burden per response. The increase in burden is due to an increase in the number of responses. The previously approved number of responses was based on an expected 80 percent response rate, while the number now reflects all the respondents in the sample. Survey response rates have been steadily increasing as respondents have become more familiar with the survey and BEA has made efforts to communicate the importance of the survey.

---

Annual Cost to Federal Government: $80,280

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/13/2020

---